Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.14 USD | +2.94% | -1.31% | -28.86% |
15/04 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
26/02 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Other languages